Richard C. Olshock, MD
NPI 1104805449ActiveIndividual· Pathology, Clinical Pathology/Laboratory Medicine· Arvada, CO
Pathology, Clinical Pathology/Laboratory Medicine (MD) in Arvada, Colorado, licensed in CO, with an NPI issued in January 2006. Takeda Pharmaceuticals U.S.A., Inc. reported $45,500 in payments in 2025, mostly consulting fees.
Overview
| NPI | 1104805449 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Jan 14, 2006 |
| Last updated in NPPES | Mar 17, 2014 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Pathology, Clinical Pathology/Laboratory Medicine Primary | 207ZP0105X | DR21801 | CO |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|
Industry payments (Open Payments)
- 2025$45,500 · 21 payments from 1 company
- 2024$21,667 · 10 payments from 1 company
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $45,500 | 21 |
What the 2025 payments were for
- Consulting Fee$45,500 · 21 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records